Associated Papers
miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease.
Suvarna V et al.
Frontiers in Pharmacology, 2022
Role of lysosomes in physiological activities, diseases, and therapy.
Zhang Z et al.
Journal of Hematology & Oncology, 2021
In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129.
Weston LJ et al.
Neurobiology of Disease, 2021
Dynamin-related protein 1: A protein critical for mitochondrial fission, mitophagy, and neuronal death in Parkinson's disease.
Feng ST et al.
Pharmacological Research, 2020
Inhibition of α-synuclein aggregation by small heat shock proteins.
Bruinsma IB et al.
Proteins, 2011
Select a paper to view details